TickerFacts.

A business in context

INO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-06 · 0001193125-26-415555 · Items 5.03,9.01

  2. 8-K · Current report

    Report date 2026-08-12 · 0001055726-26-000024 · Items 2.02,9.01

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001055726-26-000023

  4. 8-K · Current report

    Report date 2026-07-29 · 0001193125-26-326785 · Items 1.01,8.01,9.01

  5. 8-K · Current report

    Report date 2026-07-29 · 0001193125-26-323628 · Items 2.02

  6. 4 · Ownership change

    Report date 2026-05-20 · 0001936799-26-000006

  7. 4 · Ownership change

    Report date 2026-05-20 · 0001771498-26-000005

  8. 4 · Ownership change

    Report date 2026-05-20 · 0001771423-26-000001

  9. 4 · Ownership change

    Report date 2026-05-20 · 0001770390-26-000005

  10. 4 · Ownership change

    Report date 2026-05-20 · 0001741836-26-000005

  11. 4 · Ownership change

    Report date 2026-05-20 · 0001669080-26-000003

  12. 4 · Ownership change

    Report date 2026-05-20 · 0001587788-26-000002

  13. 4 · Ownership change

    Report date 2026-05-20 · 0001278219-26-000001

  14. 8-K · Current report

    Report date 2026-05-19 · 0001193125-26-232524 · Items 5.03,5.07,9.01

  15. 8-K · Current report

    Report date 2026-05-13 · 0001055726-26-000019 · Items 2.02,9.01

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001055726-26-000018

  17. DEF 14A · Proxy statement

    Report date 2026-05-20 · 0001055726-26-000011

  18. 8-K · Current report

    Report date 2026-04-02 · 0001193125-26-142885 · Items 1.01,8.01,9.01

  19. 8-K · Current report

    Report date 2026-04-01 · 0001193125-26-138870 · Items 8.01

  20. 8-K · Current report

    Report date 2026-03-12 · 0001055726-26-000009 · Items 2.02,9.01

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001055726-26-000008

  22. 8-K · Current report

    Report date 2026-01-27 · 0001193125-26-024431 · Items 1.01,3.03,9.01

  23. 8-K · Current report

    Report date 2025-12-29 · 0001193125-25-332322 · Items 7.01,8.01,9.01

  24. 8-K · Current report

    Report date 2025-11-11 · 0001193125-25-275721 · Items 1.01,8.01,9.01

  25. 8-K · Current report

    Report date 2025-11-10 · 0001055726-25-000064 · Items 2.02,9.01

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001055726-25-000063

  27. 8-K · Current report

    Report date 2025-08-12 · 0001055726-25-000056 · Items 2.02,9.01

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001055726-25-000055

  29. 8-K · Current report

    Report date 2025-07-02 · 0001193125-25-155830 · Items 1.01,8.01,9.01

  30. 8-K · Current report

    Report date 2025-05-20 · 0001055726-25-000045 · Items 5.07

  31. 8-K · Current report

    Report date 2025-05-13 · 0001055726-25-000027 · Items 2.02,9.01

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001055726-25-000026

  33. DEF 14A · Proxy statement

    Report date 2025-05-20 · 0001055726-25-000018

  34. 8-K · Current report

    Report date 2025-03-18 · 0001055726-25-000013 · Items 2.02,9.01

  35. 10-K · Annual report

    Report date 2024-12-31 · 0001055726-25-000012

  36. 8-K · Current report

    Report date 2024-12-12 · 0001193125-24-279061 · Items 1.01,8.01,9.01

  37. 8-K · Current report

    Report date 2024-11-14 · 0001055726-24-000053 · Items 2.02,9.01

  38. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001055726-24-000052

  39. SC 13G · Ownership disclosure

    0002012383-24-003609

  40. SC 13G · Ownership disclosure

    0002012383-24-001669

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001055726INOVIO PHARMACEUTICALS, INC.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
529900B9W875XDZXTM97
GLEIF legal name
Inovio Pharmaceuticals, Inc.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2021-07-15T05:09:24Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Inovio Pharmaceuticals · alias · wikidata
  • INOVIO BIOMEDICAL CORP · former SEC name · 2005-04-04 to 2010-05-11
  • GENETRONICS BIOMEDICAL CORP · former SEC name · 2001-12-04 to 2005-04-01
  • GENETRONICS BIOMEDICAL LTD · former SEC name · 1999-09-01 to 2001-08-03
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$217.8K$233.9K
2023-12-31$832.0K$920.0K
2022-12-31$10.26M$11.81M
2021-12-31$1.77M$2.21M
2020-12-31$7.41M$9.65M
2019-12-31$4.11M$5.42M
2018-12-31$30.48M$40.90M
2017-12-31$42.22M$58.03M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗